OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Passive immunotherapies for COVID‐19: The subtle line between standard and hyperimmune immunoglobulins is getting invisible
Daniele Focosi, Massimo Franchini
Reviews in Medical Virology (2022) Vol. 32, Iss. 4
Closed Access | Times Cited: 14
Daniele Focosi, Massimo Franchini
Reviews in Medical Virology (2022) Vol. 32, Iss. 4
Closed Access | Times Cited: 14
Showing 14 citing articles:
Analysis of anti-SARS-CoV-2 Omicron-neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources
David J. Sullivan, Massimo Franchini, Michael J. Joyner, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 78
David J. Sullivan, Massimo Franchini, Michael J. Joyner, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 78
COVID-19 therapeutics
Daniele Focosi, Massimo Franchini, Fabrizio Maggi, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 10
Daniele Focosi, Massimo Franchini, Fabrizio Maggi, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 10
Intravenous immunoglobulin (IVIg) therapy in hospitalised adult COVID‐19 patients: A systematic review and meta‐analysis
Robert Marčec, Vinko Michael Dodig, Igor Radanović, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 6
Open Access | Times Cited: 20
Robert Marčec, Vinko Michael Dodig, Igor Radanović, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 6
Open Access | Times Cited: 20
Passive immunotherapies for the next influenza pandemic
Daniele Focosi, Massimo Franchini, Jonathon W. Senefeld, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 3
Closed Access | Times Cited: 3
Daniele Focosi, Massimo Franchini, Jonathon W. Senefeld, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 3
Closed Access | Times Cited: 3
Analysis of anti-Omicron neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources
David J. Sullivan, Massimo Franchini, Michael J. Joyner, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 15
David J. Sullivan, Massimo Franchini, Michael J. Joyner, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 15
Immune Plasma for the Treatment of COVID-19: Lessons Learned so far
Hubert Schrezenmeier, Simone Hoffmann, Henrike Hofmann, et al.
Hämostaseologie (2023) Vol. 43, Iss. 01, pp. 067-074
Open Access | Times Cited: 5
Hubert Schrezenmeier, Simone Hoffmann, Henrike Hofmann, et al.
Hämostaseologie (2023) Vol. 43, Iss. 01, pp. 067-074
Open Access | Times Cited: 5
Polyclonal immunoglobulins for COVID-19 pre-exposure prophylaxis in immunocompromised patients
Daniele Focosi, Massimo Franchini
Transfusion and Apheresis Science (2023) Vol. 62, Iss. 3, pp. 103648-103648
Open Access | Times Cited: 4
Daniele Focosi, Massimo Franchini
Transfusion and Apheresis Science (2023) Vol. 62, Iss. 3, pp. 103648-103648
Open Access | Times Cited: 4
Serum anti‐Spike immunoglobulin G levels in random blood donors in Italy: High‐titre convalescent plasma is easier than ever to procure
Daniele Focosi, Silvia Meschi, Sabrina Coen, et al.
Vox Sanguinis (2023) Vol. 118, Iss. 9, pp. 794-797
Closed Access | Times Cited: 4
Daniele Focosi, Silvia Meschi, Sabrina Coen, et al.
Vox Sanguinis (2023) Vol. 118, Iss. 9, pp. 794-797
Closed Access | Times Cited: 4
Hyperimmune Plasma and Immunoglobulins Against COVID-19: A Narrative Review
Massimo Franchini, Daniele Focosi
(2023)
Open Access | Times Cited: 4
Massimo Franchini, Daniele Focosi
(2023)
Open Access | Times Cited: 4
Convalescent Plasma Versus Hyperimmune Immunoglobulins
Daniele Focosi, Massimo Franchini, Emanuele Nicastri, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. 9, pp. 1356-1357
Closed Access | Times Cited: 3
Daniele Focosi, Massimo Franchini, Emanuele Nicastri, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. 9, pp. 1356-1357
Closed Access | Times Cited: 3
Passive antibody therapy in emerging infectious diseases
Xiaoming Yang
Frontiers of Medicine (2023) Vol. 17, Iss. 6, pp. 1117-1134
Closed Access | Times Cited: 3
Xiaoming Yang
Frontiers of Medicine (2023) Vol. 17, Iss. 6, pp. 1117-1134
Closed Access | Times Cited: 3
Monoclonal Antibodies and Hyperimmune Immunoglobulins in the Next Pandemic
Massimo Franchini, Daniele Focosi
Current topics in microbiology and immunology (2024)
Closed Access
Massimo Franchini, Daniele Focosi
Current topics in microbiology and immunology (2024)
Closed Access
Recent Hybrid Plasma Better Neutralizes Omicron Sublineages Than Old Hyperimmune Serum
Daniele Focosi, Michael J. Joyner, Arturo Casadevall
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. 554-554
Closed Access | Times Cited: 3
Daniele Focosi, Michael J. Joyner, Arturo Casadevall
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. 554-554
Closed Access | Times Cited: 3
The Role of Convalescent Plasma in COVID-19: A Conclusive Post-Pandemic Review
Massimo Franchini, Daniele Focosi
Life (2023) Vol. 13, Iss. 12, pp. 2322-2322
Open Access | Times Cited: 1
Massimo Franchini, Daniele Focosi
Life (2023) Vol. 13, Iss. 12, pp. 2322-2322
Open Access | Times Cited: 1
